steven-a-weissman.bsky.social - Profile | ThreadSky | a Reddit-style client for Bluesky

The US National Science Foundation has terminated 1,042 active grants over the past 2 weeks, according to a list provided to C&EN by an internal NSF source, who insisted on anonymity out of fear of retribution. cen.acs.org/policy/resea... 🧪

submitted 26 days ago • 0 comments

What can we expected from the FDA moving forward ? Insights from a VC leader in the field www.linkedin.com/posts/bruceb...

submitted 57 days ago • 0 comments

Simply put, the health of every American is at greater risk today because of this.

submitted 58 days ago • 0 comments

An important take from Bloomberg's Lisa Jarvis, bravo.

submitted 58 days ago • 0 comments

The indiscriminate layoffs (aka 'RIF') at HHS have begun www.linkedin.com/news/story/m...

submitted 58 days ago • 0 comments

www.reuters.com/business/hea...

submitted 59 days ago • 0 comments

The unwarranted decimation of our scientific institutions continues with the following HHS jobs cuts: FDA :3500 workers; CDC: 2400 workers, NIH: 1220 workers. insider.thefdagroup.com/p/tracking-m...

submitted 63 days ago • 0 comments

Eisai and Novertis trim headcount in NJ njbiz.com/more-layoffs...

submitted 69 days ago • 0 comments

Welp, it only took 53 days for the rule of law to fall by the wayside.

submitted 73 days ago • 0 comments

This is egregious and unforgivable: contrarian.substack.com/p/trumps-del...

submitted 75 days ago • 0 comments

A bold strategy: www.newswire.ca/news-release...

submitted 76 days ago • 0 comments

www.newswire.ca/news-release...

submitted 76 days ago • 0 comments

🧪 The attack on science could have a generational effect. We risk losing a wave of early-career researchers to these cuts. And biomedical science in the US will be less ambitious, less competitive & lead to fewer breakthroughs. So much is at stake. My latest for @opinion.bloomberg.com (🎁 link):

submitted 78 days ago • 6 comments

www.raps.org/News-and-Art...

submitted 83 days ago • 0 comments

www.raps.org/news-and-art...

submitted 83 days ago • 0 comments

Another clue in the origins of Alzheimer's disease www.science.org/content/blog...

submitted 94 days ago • 0 comments

www.biospace.com/fda/no-job-s...

submitted 99 days ago • 0 comments

The development story behind the second generation synthesis of Cognition Therapeutics' sigma-2 receptor modulator, zervimesine (CT1812) can be found here: pubs.acs.org/doi/10.1021/... #chemsky #OPRD

submitted 120 days ago • 0 comments

It's 2025 and methylene chloride is amazingly still the solvent of choice for decaffeinating coffee. cen.acs.org/food/food-sc...

submitted 120 days ago • 0 comments

A new indication for Ozempic www.nytimes.com/2025/01/28/w...

submitted 120 days ago • 0 comments

Great news for DLB patients. ir.cogrx.com/press_releas...

submitted 162 days ago • 0 comments

TCE and PCE to be banned by EPA within 3 yeas cen.acs.org/policy/chemi...

submitted 169 days ago • 0 comments

Appears the BIOSECURE Act has lost steam www.fiercepharma.com/pharma/biose...

submitted 170 days ago • 0 comments

www.fiercepharma.com/pharma/green...

submitted 170 days ago • 0 comments

For a disease like #lewybodydementia, which has such a variety of symptoms, it's important to understand what impacts patients and their care partners most significantly. A survey of people living with #DLB and their care partners is underway: bitl.to/3Jg9. #dementia #dementiaresearch #caregiving

submitted 174 days ago • 0 comments

The skinny on weight loss drugs. A clear victor has emerged: www.fiercepharma.com/pharma/head-...

submitted 176 days ago • 0 comments

Another wave of layoffs at BMS in NJ for 2025: www.fiercepharma.com/pharma/brist...

submitted 184 days ago • 0 comments

Baird analyst thinks Pharma shake-up unlikely under Trump 2.0 www.fiercepharma.com/pharma/bioph...

submitted 188 days ago • 0 comments

60% workforce reduction at Lexicon after FDA troubles with Zynqista application www.fiercepharma.com/pharma/back-...

submitted 188 days ago • 0 comments

A new commercial blood test can now help detect Alzheimer's disease: time.com/7094900/alzp...

submitted 188 days ago • 0 comments

Setback for Neurogene's Rett syndrome candidate www.tipranks.com/news/company...

submitted 188 days ago • 0 comments

The US National Science Foundation has terminated 1,042 active grants over the past 2 weeks, according to a list provided to C&EN by an internal NSF source, who insisted on anonymity out of fear of retribution. cen.acs.org/policy/resea... 🧪

What can we expected from the FDA moving forward ? Insights from a VC leader in the field www.linkedin.com/posts/bruceb...

Simply put, the health of every American is at greater risk today because of this.

An important take from Bloomberg's Lisa Jarvis, bravo.

The indiscriminate layoffs (aka 'RIF') at HHS have begun www.linkedin.com/news/story/m...

www.reuters.com/business/hea...

The unwarranted decimation of our scientific institutions continues with the following HHS jobs cuts: FDA :3500 workers; CDC: 2400 workers, NIH: 1220 workers. insider.thefdagroup.com/p/tracking-m...

Eisai and Novertis trim headcount in NJ njbiz.com/more-layoffs...

Welp, it only took 53 days for the rule of law to fall by the wayside.

This is egregious and unforgivable: contrarian.substack.com/p/trumps-del...

A bold strategy: www.newswire.ca/news-release...

www.newswire.ca/news-release...

www.raps.org/News-and-Art...

www.raps.org/news-and-art...

Another clue in the origins of Alzheimer's disease www.science.org/content/blog...

www.biospace.com/fda/no-job-s...

The development story behind the second generation synthesis of Cognition Therapeutics' sigma-2 receptor modulator, zervimesine (CT1812) can be found here: pubs.acs.org/doi/10.1021/... #chemsky #OPRD

It's 2025 and methylene chloride is amazingly still the solvent of choice for decaffeinating coffee. cen.acs.org/food/food-sc...

A new indication for Ozempic www.nytimes.com/2025/01/28/w...

Great news for DLB patients. ir.cogrx.com/press_releas...

TCE and PCE to be banned by EPA within 3 yeas cen.acs.org/policy/chemi...

Appears the BIOSECURE Act has lost steam www.fiercepharma.com/pharma/biose...

www.fiercepharma.com/pharma/green...

For a disease like #lewybodydementia, which has such a variety of symptoms, it's important to understand what impacts patients and their care partners most significantly. A survey of people living with #DLB and their care partners is underway: bitl.to/3Jg9. #dementia #dementiaresearch #caregiving

The skinny on weight loss drugs. A clear victor has emerged: www.fiercepharma.com/pharma/head-...

Another wave of layoffs at BMS in NJ for 2025: www.fiercepharma.com/pharma/brist...

Baird analyst thinks Pharma shake-up unlikely under Trump 2.0 www.fiercepharma.com/pharma/bioph...

60% workforce reduction at Lexicon after FDA troubles with Zynqista application www.fiercepharma.com/pharma/back-...

A new commercial blood test can now help detect Alzheimer's disease: time.com/7094900/alzp...

Setback for Neurogene's Rett syndrome candidate www.tipranks.com/news/company...

CNS drug development takes its toll: Sage Pharma www.science.org/content/blog...

The future of synthesis ? cen.acs.org/synthesis/AI...

Industrial safety alert: cen.acs.org/safety/consu...